2025 annual financial data
Aldeyra Therapeutics 2025 Net margin
Direct answer
Net margin was Not calculable.
Operating income was -35,265,206 USD and net income was -33,846,661 USD.
Operating cash flow was -33,345,682 USD.
Get free Aldeyra Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -35,265,206 USD
- Net income
- -33,846,661 USD
- Operating cash flow
- -33,345,682 USD
Explore related company data
View all 2025 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all Aldeyra Therapeutics financial years